Reported figures and Equlion model projections for the next 5 years.
Metric
2025 (actual)
2026 (forecast)
2027
2028
2029
2030
2031
Trend
ROE
-16.29%
-22.73%
-26.04%
-39.96%
-80.48%
-553.17%
125.11%
ROA
-15.22%
-20.59%
-22.13%
-31.64%
-51.34%
-71.46%
-78.49%
Gross Margin
81.37%
85.44%
85.44%
85.44%
85.44%
85.44%
85.44%
Sector average
-
17.71%
17.71%
17.71%
17.71%
17.71%
62.35%
Net Margin
Amounts in SEK (thousands); stock price per share. Values that are missing or fail Equlion's automated data-quality checks are shown as “-”. Stock price and valuation carry no data date: they are the Equlion model's estimate for 2026. Projections are model estimates, not investment advice.
Want the full financial forecast report for Corline Biomedical AB? It covers the balance sheet, income statement and Equlion model projections.
-192.31%
-134.54%
-134.53%
-134.58%
-134.64%
-134.67%
-134.69%
Total Assets
SEK 98,578.00K
SEK 114,183.00K
SEK 91,997.83K
SEK 68,391.77K
SEK 45,207.31K
SEK 43,819.14K
SEK 42,618.36K
Sector average
-
SEK 2,900,240.60K
SEK 3,045,009.79K
SEK 3,280,286.42K
SEK 3,536,407.14K
SEK 3,762,908.71K
SEK 1,806,991.80K
Net Income
-SEK 14,714.00K
-SEK 21,908.19K
-SEK 22,812.78K
-SEK 25,376.00K
-SEK 29,158.79K
-SEK 31,806.94K
-SEK 33,924.12K
Sector average
-
-SEK 22,027.28K
-SEK 904.69K
-SEK 7,253.84K
-SEK 3,858.45K
-SEK 1,547.00K
-SEK 13,704.11K
Valuation
-
SEK 428,583.12K
SEK 446,279.39K
SEK 496,422.78K
SEK 570,424.37K
SEK 622,229.25K
SEK 663,646.98K
Sector average
-
SEK 5,151,301.60K
SEK 5,189,236.02K
SEK 5,317,343.69K
SEK 5,514,329.75K
SEK 5,636,782.17K
SEK 3,179,755.44K
Stock Price
-
SEK 16.40
SEK 17.08
SEK 19.00
SEK 21.83
SEK 23.81
SEK 25.39
Sector average
-
SEK 48.04
SEK 48.69
SEK 50.45
SEK 52.13
SEK 53.41
SEK 36.70
Corline Biomedical AB (CLBIO.ST) Financial Forecast | Equlion
